Adherence to inhaled antibiotics in people with cystic fibrosis: insights from a virtual patient advisory board

CONCLUSIONS: PwCF on CFTR modulators are questioning the necessity of continuing chronic medications and therapies. Physicians are urged to carefully consider the balance between simplifying antibiotic treatment and the risk of clinical deterioration due to bacterial infections when making treatment decisions. Furthermore, the development and global harmonization of diagnostic tools for chronic lung damage and treatment guidelines are crucial to justify the demanding routines that PwCF must endure to manage their condition.The heterogeneity in patient journeys, diagnostic challenges, treatment complexity, and issues related to adherence highlight the need for patient-centric, personalized care that emphasizes improving and maintaining treatment adherence to optimize cystic fibrosis management.PMID:37817635 | DOI:10.1080/17476348.2023.2267427
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research